My Biggest Takeaway from the 2018 Cholesterol Guidelines
In late 2018, ACC and AHA came out with an update to their cholesterol guidelines. The last update was from 2013 so PCSK-9 inhibitors hadn’t even been approved at that time. Very High Risk Patients – My Biggest Takeaway I always had a hard time knowing when to recommend further lipid lowering therapy to a […]
Read More